Alimera Sciences
(NASDAQ) ALIM
This security has been delisted. This page is retained for historical reference.
ALIM News
2 Stocks Stopping the Presses
Alimera Annihilates Its Doubters
5 of Last Week's Biggest Losers
These 2 Biotechs Got Crushed
Hidden Stocks for High Returns
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowALIM Financials
Key Financial Metrics (TTM)
Gross Margin
75.75%
Operating Margin
-2.39%
Net Income Margin
-24.93%
Return on Equity
-159.01%
Return on Capital
-1.70%
Return on Assets
-13.11%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-6.25%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$79.87M
Operating Income
$199.00K
EBITDA
$11.38M
Operating Cash Flow
-$5.60M
Capital Expenditure
-$221.00K
Free Cash Flow
-$5.82M
Cash & ST Invst.
$10.86M
Total Debt
$72.16M
Alimera Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$27.00M
+54.0%
Gross Profit
$23.17M
+53.3%
Gross Margin
85.81%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
154
N/A
Net Income
-$3.31M
+67.0%
EBITDA
$2.89M
+144.9%
Quarterly Fundamentals
Total Cash
$10.86M
-42.2%
Total Debt
$72.16M
+12.5%
Accounts Receivable
$37.08M
+64.1%
Inventory
$3.46M
+227.5%
Long Term Debt
$69.73M
+9.0%
Short Term Debt
$245.00K
+20.7%
Return on Assets
-13.11%
N/A
Return on Invested Capital
-1.47%
N/A
Free Cash Flow
$915.00K
+101.1%
Operating Cash Flow
$1.03M
+117.1%